Title : ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer.

Pub. Date : 2020 Jan 15

PMID : 30194031






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer. ODM-204 cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 INTERVENTION: ODM-204, a novel, orally administered, investigational, nonsteroidal dual inhibitor of CYP17A1 and androgen receptor. ODM-204 cytochrome P450 family 17 subfamily A member 1 Homo sapiens